Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines
Using adjuvants to drive features of T cell responses to vaccine antigens is an important technological challenge in the design of new and improved vaccines against infections. Properties such as T helper cell function, T cell memory, and CD8+ T cell cytotoxicity may play critical roles in optimal a...
Main Authors: | Rekha R. Rapaka, Alan S. Cross, Monica A. McArthur |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/8/820 |
Similar Items
-
CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity
by: Alsya J. Affandi, et al.
Published: (2021-07-01) -
Understanding the biology of antigen cross-presentation for the design of vaccines against cancer
by: Cynthia M. Fehres, et al.
Published: (2014-04-01) -
Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells
by: Tyler C. Moore, et al.
Published: (2019-01-01) -
Immunodominant Cytomegalovirus Epitopes Suppress Subdominant Epitopes in the Generation of High-Avidity CD8 T Cells
by: Kirsten Freitag, et al.
Published: (2021-07-01) -
APC Licensing and CD4+ T Cell Help in Liver-Stage Malaria
by: Ian Nicholas Crispe
Published: (2014-11-01)